Strattera is a prescription drug approved by the Food and Drug Administration (FDA) in 2002 for treating attention-deficit hyperactivity disorder (ADHD). As many as 30 percent of children diagnosed with autism spectrum disorders (ASD) also have problems with ADHD. Strattera can help improve symptoms of ADHD in autistic children. Strattera is also known by its drug name, Atomoxetine hydrochloride.
Strattera is not appropriate for pregnant women or people with a history of heart disease, high blood pressure, glaucoma, or pheochromocytoma, a tumor in the adrenal glands. Strattera should be used with caution in people with a history of liver problems, depression, and psych... read more